Punding in Parkinson's disease.
O'Sullivan
Sean S
SS
Reta Lila Weston Institute of Neurological Studies, Institute of Neurology, University College London, London, UK.
Evans
Andrew H
AH
Lees
Andrew J
AJ
D000328:Adult; D000978:Antiparkinson Agents / Q000009:adverse effects; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000503:physiopathology*; D004298:Dopamine / Q000378:metabolism*; D018491:Dopamine Agonists / Q000009:adverse effects; D006801:Humans; D007175:Impulsive Behavior / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology; D008297:Male; D001523:Mental Disorders / Q000209:etiology* / Q000503:physiopathology / Q000523:psychology; D009771:Obsessive-Compulsive Disorder / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D010300:Parkinson Disease / Q000150:complications* / Q000503:physiopathology / Q000523:psychology
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D018491:Dopamine Agonists; D004298:Dopamine